ArticleClinical & experimental metastasis2013

Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma.

Einar Birkeland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.